Selection of Recent Oncology Articles Published in The Lancet

On this page, you will find links to the latest oncology-related research articles published in The Lancet.

Filter

Date Title Topic
09 Jun 2018 Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-la... Anti-Cancer Agents & Biologic Therapy , Gastric Cancer
15 May 2018 Immunoscore for (colorectal) cancer precision medicine. Colon Cancer , Rectal Cancer , Personalised Medicine
13 Feb 2018 Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority tr... Cancer Immunology and Immunotherapy , Hepatobiliary Cancers
06 Feb 2018 Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of... Cancer Aetiology, Epidemiology, Prevention
23 Dec 2017 Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre,... Cancer Immunology and Immunotherapy , Urothelial Cancers
21 Oct 2017 Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNO... Cancer Immunology and Immunotherapy , Melanoma and other Skin Tumours
20 Oct 2017 PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 t... Haematologic Malignancies , Lymphomas , Imaging, Diagnosis and Staging
05 Oct 2017 Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemothera... Cancer Immunology and Immunotherapy , Gastrointestinal Cancers , Gastric Cancer
12 Sep 2017 Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based... Cancer Immunology and Immunotherapy , Genitourinary Cancers , Urothelial Cancers
12 Sep 2017 Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-co... Cancer Immunology and Immunotherapy , Gynaecologic Malignancies , Ovarian Cancer
09 Sep 2017 CAR T-cells: an exciting frontier in cancer therapy. Cancer Immunology and Immunotherapy , Translational Research
08 Aug 2017 Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted an... Anti-Cancer Agents & Biologic Therapy , Central Nervous System Malignancies
29 Jul 2017 Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Anti-Cancer Agents & Biologic Therapy , Gastrointestinal Cancers , Rectal Cancer , Surgery and/or Radiotherapy of Cancer
27 Jul 2017 Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial... Cancer Immunology and Immunotherapy , Gynaecologic Malignancies , Cervical Cancer
01 Jul 2017 J-ALEX: alectinib versus crizotinib in ALK-positive lung cancer. Cancer Immunology and Immunotherapy , Lung and other Thoracic Tumours